MicroRNA Profiling of Salivary Adenoid Cystic Carcinoma: Association of miR-17-92 Upregulation with Poor Outcome

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Mitani, Yoshitsugu ^a   Roberts, Dianna B ^a   Fatani, Hanadi ^a   Weber, Randal S ^a   Kies, Merrill S ^a   Lippman, Scott M ^b   El Naggar, Adel K ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 17 92; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADENOID CYSTIC CARCINOMA; ADULT; ARTICLE; CANCER SURVIVAL; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUSION; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MYB NFIB FUSION GENE; ONCOGENE; PROTEIN BINDING; SALIVARY GLAND CARCINOMA; SURVIVAL RATE; UPREGULATION; VALIDATION PROCESS;

CARCINOGENESIS; CARCINOMA, ADENOID CYSTIC; FEMALE; GENE EXPRESSION PROFILING; GENE FUSION; GENES, MYB; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NFI TRANSCRIPTION FACTORS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SALIVARY GLAND NEOPLASMS; SURVIVAL ANALYSIS; UP-REGULATION;

EID: 84879344558     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066778     Document Type: Article

References (55)

1. Chomette G, Auriol M, Tranbaloc P, Vaillant JM, (1982) Adenoid cystic carcinoma of minor salivary glands. Analysis of 86 cases. Clinico-pathological, histoenzymological and ultrastructural studies. Virchows Arch A Pathol Anat Histol 395: 289-301.
2. Batsakis JG, Luna MA, El-Naggar A, (1990) Histopathologic grading of salivary gland neoplasms: III. Adenoid cystic carcinomas. Ann Otol Rhinol Laryngol 99: 1007-1009.
3. Spiro RH, (1986) Salivary neoplasms: overview of a 35-year experience with 2,807 patients. Head Neck Surg 8: 177-184.
4. Fordice J, Kershaw C, El-Naggar A, Goepfert H, (1999) Adenoid cystic carcinoma of the head and neck: predictors of morbidity and mortality. Arch Otolaryngol Head Neck Surg 125: 149-152.
5. El-Naggar AK, Huvos AG (2005) Adenoid cystic carcinoma. In: Barnes L, Eveson JW, Reichart P, Sidransky D, editors. World Health Organization Classification of Tumors Pathology and Genetics of Head and Neck Tumors: IARC Press, Lyon, France. 221-222.
6. Ambros V, (2008) The evolution of our thinking about microRNAs. Nat Med 14: 1036-1040.
7. Kim VN, (2005) MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol 6: 376-385.
8. Rao PH, Roberts D, Zhao YJ, Bell D, Harris CP, et al. (2008) Deletion of 1p32-p36 is the most frequent genetic change and poor prognostic marker in adenoid cystic carcinoma of the salivary glands. Clin Cancer Res 14: 5181-5187.
9. Rigoutsos I, (2009) New tricks for animal microRNAS: targeting of amino acid coding regions at conserved and nonconserved sites. Cancer Res 69: 3245-3248.
10. van Kouwenhove M, Kedde M, Agami R, (2011) MicroRNA regulation by RNA-binding proteins and its implications for cancer. Nat Rev Cancer 11: 644-656.
11. Calin GA, Croce CM, (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866.
12. Ma L, Weinberg RA, (2008) MicroRNAs in malignant progression. Cell Cycle 7: 570-572.
13. Sotiropoulou G, Pampalakis G, Lianidou E, Mourelatos Z, (2009) Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell. RNA 15: 1443-1461.
14. Thomson JM, Newman M, Parker JS, Morin-Kensicki EM, Wright T, et al. (2006) Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev 20: 2202-2207.
15. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, et al. (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 101: 2999-3004.
16. Zhang X, Cairns M, Rose B, O'Brien C, Shannon K, et al. (2009) Alterations in miRNA processing and expression in pleomorphic adenomas of the salivary gland. Int J Cancer 124: 2855-2863.
17. Mitani Y, Li J, Rao PH, Zhao YJ, Bell D, et al. (2010) Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: Incidence, variability, and clinicopathologic significance. Clin Cancer Res 16: 4722-4731.
18. Persson M, Andren Y, Mark J, Horlings HM, Persson F, et al. (2009) Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc Natl Acad Sci U S A 106: 18740-18744.
19. Harper ME, Franchini G, Love J, Simon MI, Gallo RC, et al. (1983) Chromosomal sublocalization of human c-myb and c-fes cellular onc genes. Nature 304: 169-171.
20. Ramsay RG, Gonda TJ, (2008) MYB function in normal and cancer cells. Nat Rev Cancer 8: 523-534.
21. Mitani Y, Rao PH, Futreal PA, Roberts DB, Stephens PJ, et al. (2011) Novel chromosomal rearrangements and break points at the t(6;9) in salivary adenoid cystic carcinoma: association with MYB-NFIB chimeric fusion, MYB expression, and clinical outcome. Clin Cancer Res 17: 7003-7014.
22. Lee J, Li Z, Brower-Sinning R, John B, (2007) Regulatory circuit of human microRNA biogenesis. PLoS Comput Biol 3: e67.
23. Ritchie ME, Silver J, Oshlack A, Holmes M, Diyagama D, et al. (2007) A comparison of background correction methods for two-colour microarrays. Bioinformatics 23: 2700-2707.
24. Tusher VG, Tibshirani R, Chu G, (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98: 5116-5121.
25. Andersen CL, Jensen JL, Orntoft TF, (2004) Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 64: 5245-5250.
26. Jevnaker AM, Khuu C, Kjole E, Bryne M, Osmundsen H, (2011) Expression of members of the miRNA17-92 cluster during development and in carcinogenesis. J Cell Physiol 226: 2257-2266.
27. Mendell JT, (2008) miRiad roles for the miR-17-92 cluster in development and disease. Cell 133: 217-222.
28. Olive V, Jiang I, He L, (2010) mir-17-92, a cluster of miRNAs in the midst of the cancer network. Int J Biochem Cell Biol 42: 1348-1354.
29. Hiroki E, Akahira J, Suzuki F, Nagase S, Ito K, et al. (2010) Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas. Cancer Sci 101: 241-249.
30. Ujifuku K, Mitsutake N, Takakura S, Matsuse M, Saenko V, et al. (2010) miR-195, miR-455-3p and miR-10a(*) are implicated in acquired temozolomide resistance in glioblastoma multiforme cells. Cancer Lett 296: 241-248.
31. Wald AI, Hoskins EE, Wells SI, Ferris RL, Khan SA, (2011) Alteration of microRNA profiles in squamous cell carcinoma of the head and neck cell lines by human papillomavirus. Head Neck 33: 504-512.
32. Pekarsky Y, Santanam U, Cimmino A, Palamarchuk A, Efanov A, et al. (2006) Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res 66: 11590-11593.
33. Schaefer A, Jung M, Mollenkopf HJ, Wagner I, Stephan C, et al. (2010) Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int J Cancer 126: 1166-1176.
34. Ventura A, Young AG, Winslow MM, Lintault L, Meissner A, et al. (2008) Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 132: 875-886.
35. Tchernitsa O, Kasajima A, Schafer R, Kuban RJ, Ungethum U, et al. (2010) Systematic evaluation of the miRNA-ome and its downstream effects on mRNA expression identifies gastric cancer progression. J Pathol 222: 310-319.
36. Cho WC, Chow AS, Au JS, (2009) Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation. Eur J Cancer 45: 2197-2206.
37. Abraham D, Jackson N, Gundara JS, Zhao J, Gill AJ, et al. (2011) MicroRNA profiling of sporadic and hereditary medullary thyroid cancer identifies predictors of nodal metastasis, prognosis, and potential therapeutic targets. Clin Cancer Res 17: 4772-4781.
38. Tran N, O'Brien CJ, Clark J, Rose B, (2010) Potential role of micro-RNAs in head and neck tumorigenesis. Head Neck 32: 1099-1111.
39. Huang G, Nishimoto K, Zhou Z, Hughes D, Kleinerman ES, (2012) miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression. Cancer Res 72: 908-916.
40. Saito M, Schetter AJ, Mollerup S, Kohno T, Skaug V, et al. (2011) The association of microRNA expression with prognosis and progression in early-stage, non-small cell lung adenocarcinoma: a retrospective analysis of three cohorts. Clin Cancer Res 17: 1875-1882.
41. De Preter K, Mestdagh P, Vermeulen J, Zeka F, Naranjo A, et al. (2011) miRNA expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samples. Clin Cancer Res 17: 7684-7692.
42. de Souza Rocha Simonini P, Breiling A, Gupta N, Malekpour M, Youns M, et al. (2010) Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells. Cancer Res 70: 9175-9184.
43. Hui AB, Lenarduzzi M, Krushel T, Waldron L, Pintilie M, et al. (2010) Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. Clin Cancer Res 16: 1129-1139.
44. Mathe EA, Nguyen GH, Bowman ED, Zhao Y, Budhu A, et al. (2009) MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin Cancer Res 15: 6192-6200.
45. Wang H, Garzon R, Sun H, Ladner KJ, Singh R, et al. (2008) NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell 14: 369-381.
46. Duursma AM, Kedde M, Schrier M, le Sage C, Agami R, (2008) miR-148 targets human DNMT3b protein coding region. RNA 14: 872-877.
47. Haflidadottir BS, Bergsteinsdottir K, Praetorius C, Steingrimsson E, (2010) miR-148 regulates Mitf in melanoma cells. PLoS One 5: e11574.
48. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, et al. (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070.
49. Philippidou D, Schmitt M, Moser D, Margue C, Nazarov PV, et al. (2010) Signatures of microRNAs and selected microRNA target genes in human melanoma. Cancer Res 70: 4163-4173.
50. Lujambio A, Calin GA, Villanueva A, Ropero S, Sanchez-Cespedes M, et al. (2008) A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci U S A 105: 13556-13561.
51. Sempere LF, Christensen M, Silahtaroglu A, Bak M, Heath CV, et al. (2007) Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res 67: 11612-11620.
52. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, et al. (2008) The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10: 593-601.
53. Lin YC, Kuo MW, Yu J, Kuo HH, Lin RJ, et al. (2008) c-Myb is an evolutionary conserved miR-150 target and miR-150/c-Myb interaction is important for embryonic development. Mol Biol Evol 25: 2189-2198.
54. Xiao C, Calado DP, Galler G, Thai TH, Patterson HC, et al. (2007) MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 131: 146-159.
55. Mi S, Li Z, Chen P, He C, Cao D, et al. (2010) Aberrant overexpression and function of the miR-17-92 cluster in MLL-rearranged acute leukemia. Proc Natl Acad Sci U S A 107: 3710-3715.